| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.055 | 0.06 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.06 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.07 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.097 | 0.07 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |